Companies
- Companies
- Company details
Valeant Pharmaceuticals International
Summary
ICN Pharmaceuticals was founded as International Chemical and Nuclear Corporation in 1960. In 2003, ICN changed its name to Valeant Pharmaceuticals International signifying the core principles and values underpinning the company and its new strategic focus. Valeant Pharmaceuticals has made a major commitment to invest in its research facilities and intellectual capital by increasing its financial commitment to R&D, upgrading its research facilities and employing the latest technologies to unlock the potential of its nucleoside library. ICN Photonics and ICN Medical Alliance are the subsidiary companies of Valeant Pharmaceuticals.
Partnerships
To view this information, you must subscribe to Pharmalicensing Intelligence.
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Board of directors
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Apr 2010 - 28 pages - $99
Dec 2010 - 136 pages - $500
Feb 2011 - 46 pages - $125
May 2011 - 56 pages - $125
Nov 2010 - 1079 pages - $600
Sep 2010 - 565 pages - $750
Nov 2010 - 770 pages - $750
Nov 2010 - 135 pages - $600
Jul 2010 - 41 pages - $750
Sep 2010 - 183 pages - $600
Head office
Valeant Pharmaceuticals International
Valeant Pharmaceuticals International
One Enterprise
Aliso Viejo
California
California
92626
California (USA)
Valeant Pharmaceuticals International
One Enterprise
Aliso Viejo
California
California
92626
California (USA)
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us